Comparison 2. HALOPERIDOL DECANOATE vs ORAL HALOPERIDOL.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Global impression: Not improved ‐ at 4 months (CGI)	1	22	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.61 [0.09, 4.28]
2 Mental state: BPRS ‐ at 4 months (endpoint score, high=poor)	1	22	Mean Difference (IV, Fixed, 95% CI)	3.20 [‐2.19, 8.59]
3 Side effects: 1. Movement disorders ‐ needing anticholinergic drugs.	1	22	Peto Odds Ratio (Peto, Fixed, 95% CI)	3.21 [0.39, 26.67]
4 Side effects: 2. Extrapyramidal symptoms ‐ skewed data (Bordeleau Scale).			Other data	No numeric data